Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004921 |
---|---|
Receipt number | R000005852 |
Scientific Title | Phase I trial of S-1 plus Lapatinib in patients with HER-2 positive metastatic breast cancer |
Date of disclosure of the study information | 2011/01/21 |
Last modified on | 2018/02/09 09:30:18 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/01/21 11:28:06 | ||
2 | Update | 2017/07/29 22:33:29 | TEL TEL Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2018/02/09 09:30:18 | Recruitment status |